Efficacy and safety of sofosbuvir plus ribavirin for Korean patients with hepatitis C virus genotype 2 infection: A retrospective multi-institutional study

BACKGROUND/AIMS: Sofosbuvir plus ribavirin is a standard treatment for patients infected with chronic hepatitis C virus (HCV) genotype 2 in Korea. The purpose of this study was to examine the efficacy and safety of this treatment in Korean patients with chronic HCV genotype 2 infection. METHODS: We...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Clin Mol Hepatol
Главные авторы: Kim, Young Min, Kim, Suk Bae, Song, Il Han, Lee, Sae Hwan, Kim, Hong Soo, Lee, Tae Hee, Kang, Young Woo, Kim, Seok Hyun, Lee, Byung Seok, Chae, Hee Bok, Song, Myeong Jun, Jang, Ji Woong, Ko, Soon Young, Lee, Jae Dong
Формат: Artigo
Язык:Inglês
Опубликовано: The Korean Association for the Study of the Liver 2018
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6166109/
https://ncbi.nlm.nih.gov/pubmed/29865774
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2017.0070
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы